Devises / AMRX
AMRX: Amneal Pharmaceuticals Inc - Class A
9.56
USD
0.01
(0.10%)
Le taux de change de AMRX a changé de 0.10% aujourd'hui. Au cours de la journée, l'instrument a été échangé à un minimum de 9.41 et à un maximum de 9.58.
Suivez la dynamique Amneal Pharmaceuticals Inc - Class A. Les cotations en temps réel vous aideront à réagir rapidement aux changements du marché. En basculant entre différentes périodes, vous pouvez surveiller les tendances et la dynamique des taux de change par minutes, heures, jours, semaines et mois. Utilisez ces informations pour prévoir les changements du marché et prendre des décisions de trading éclairées.
- M5
- M15
- M30
- H1
- H4
- D1
- W1
- MN
AMRX Nouvelles
- Rigel Pharmaceuticals, Inc. (RIGL) Soars to 52-Week High, Time to Cash Out?
- Amneal Pharmaceuticals stock hits 52-week high at 9.71 USD
- Amneal Pharmaceuticals stock hits 52-week high at 9.48 USD
- Wall Street Analysts See a 27.66% Upside in Amneal (AMRX): Can the Stock Really Move This High?
- Are Medical Stocks Lagging Boston Scientific (BSX) This Year?
- Here's Why Momentum in Amneal (AMRX) Should Keep going
- Amneal (AMRX) Q2 EPS Jumps 56%
- Amneal (AMRX) Q2 Earnings: Taking a Look at Key Metrics Versus Estimates
- Amneal Pharmaceuticals (AMRX) Q2 Earnings Top Estimates
- Amneal Pharma A earnings beat by $0.08, revenue fell short of estimates
- Amneal Pharmaceuticals beats Q2 estimates, raises full-year outlook
- Viatris Poised to Report Q2 Earnings: What's in Store for the Stock?
- Nektar Gears Up to Report Q2 Earnings: What's in the Cards?
- Bio-Techne Q4 Earnings Preview: What's in Store for the Stock?
- Amneal (AMRX) is an Incredible Growth Stock: 3 Reasons Why
- Amneal Pharmaceuticals (AMRX) Earnings Expected to Grow: Should You Buy?
- Wall Street Analysts Think Amneal (AMRX) Could Surge 43.82%: Read This Before Placing a Bet
- Is Amneal Pharmaceuticals (AMRX) Outperforming Other Medical Stocks This Year?
- Amneal Pharmaceuticals prices $600 million in senior secured notes, increases term loan
- Amneal seeks to borrow $1.8 billion in new term loans, offers notes
- Jazz Pharmaceuticals: I See Big Potential In This Stock As An Investor (NASDAQ:JAZZ)
- Amneal reports positive phase 3 results for XOLAIR biosimilar
- Amneal Pharmaceuticals director Patel sells $761k in stock
- Organon Stock: Persistent Headwinds Make This A Hold (NYSE:OGN)
Range quotidien
9.41
9.58
Range Annuel
6.69
9.79
- Clôture Précédente
- 9.55
- Ouverture
- 9.57
- Bid
- 9.56
- Ask
- 9.86
- Plus Bas
- 9.41
- Plus Haut
- 9.58
- Volume
- 2.957 K
- Changement quotidien
- 0.10%
- Changement Mensuel
- 23.83%
- Changement à 6 Mois
- 9.89%
- Changement Annuel
- 11.94%
31 août, dimanche